ClinicalTrials.govpublic full text
PD-1 Antibody Plus Chemoradiotherapy for IB2-IIIB Cervical Cancer
cervical carcinoma, chemoradiotherapy, anti-programmed cell death receptor 1, immunotherapy, immune checkpoint inhibitor, survival outcomes
ClinicalTrials.gov
Show glossary
Search for terms
Hide glossary
Study record managers: refer to the
Data Element Definitions
if submitting registration or results information.
Record · ID 121352 · SHA-256 e5bfa50054351e7a
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.